JP2024545184A5 - - Google Patents

Info

Publication number
JP2024545184A5
JP2024545184A5 JP2024534648A JP2024534648A JP2024545184A5 JP 2024545184 A5 JP2024545184 A5 JP 2024545184A5 JP 2024534648 A JP2024534648 A JP 2024534648A JP 2024534648 A JP2024534648 A JP 2024534648A JP 2024545184 A5 JP2024545184 A5 JP 2024545184A5
Authority
JP
Japan
Prior art keywords
alkyl
cycloalkyl
heteroaryl
aryl
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024534648A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024545184A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/052404 external-priority patent/WO2023107696A2/en
Publication of JP2024545184A publication Critical patent/JP2024545184A/ja
Priority to JP2025137487A priority Critical patent/JP2025170331A/ja
Publication of JP2024545184A5 publication Critical patent/JP2024545184A5/ja
Pending legal-status Critical Current

Links

JP2024534648A 2021-12-09 2022-12-09 メニン-mll相互作用の阻害剤 Pending JP2024545184A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025137487A JP2025170331A (ja) 2021-12-09 2025-08-21 メニン-mll相互作用の阻害剤

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202163287716P 2021-12-09 2021-12-09
US63/287,716 2021-12-09
US202263306399P 2022-02-03 2022-02-03
US63/306,399 2022-02-03
US202263397322P 2022-08-11 2022-08-11
US63/397,322 2022-08-11
PCT/US2022/052404 WO2023107696A2 (en) 2021-12-09 2022-12-09 Inhibitors of menin-mll interaction

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025137487A Division JP2025170331A (ja) 2021-12-09 2025-08-21 メニン-mll相互作用の阻害剤

Publications (2)

Publication Number Publication Date
JP2024545184A JP2024545184A (ja) 2024-12-05
JP2024545184A5 true JP2024545184A5 (cg-RX-API-DMAC7.html) 2025-08-29

Family

ID=86731242

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2024534648A Pending JP2024545184A (ja) 2021-12-09 2022-12-09 メニン-mll相互作用の阻害剤
JP2025137487A Pending JP2025170331A (ja) 2021-12-09 2025-08-21 メニン-mll相互作用の阻害剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025137487A Pending JP2025170331A (ja) 2021-12-09 2025-08-21 メニン-mll相互作用の阻害剤

Country Status (11)

Country Link
US (2) US20250163061A1 (cg-RX-API-DMAC7.html)
EP (1) EP4444300A4 (cg-RX-API-DMAC7.html)
JP (2) JP2024545184A (cg-RX-API-DMAC7.html)
KR (2) KR20240117133A (cg-RX-API-DMAC7.html)
CN (1) CN118647378A (cg-RX-API-DMAC7.html)
AU (2) AU2022405438A1 (cg-RX-API-DMAC7.html)
CA (1) CA3240074A1 (cg-RX-API-DMAC7.html)
JO (1) JOP20240130A1 (cg-RX-API-DMAC7.html)
MX (2) MX2024007069A (cg-RX-API-DMAC7.html)
TW (1) TW202529770A (cg-RX-API-DMAC7.html)
WO (1) WO2023107696A2 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202529770A (zh) * 2021-12-09 2025-08-01 美商巴拉療法公司 梅嫩蛋白(menin)-MLL相互作用之抑制劑

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016197027A1 (en) * 2015-06-04 2016-12-08 Kura Oncology, Inc. Methods and compositions for inhibiting the interaction of menin with mll proteins
BR112018012707A2 (pt) * 2015-12-22 2019-01-29 Vitae Pharmaceuticals Inc inibidores da interação de menin-mll
TW201920170A (zh) * 2017-09-20 2019-06-01 美商庫拉腫瘤技術股份有限公司 經取代之menin-mll 抑制劑及使用方法
TW202529770A (zh) * 2021-12-09 2025-08-01 美商巴拉療法公司 梅嫩蛋白(menin)-MLL相互作用之抑制劑

Similar Documents

Publication Publication Date Title
KR102866499B1 (ko) Tead 전사인자의 신규한 소분자 저해제
JP6805220B2 (ja) 治療上活性な化合物およびそれらの使用方法
AU2018358157B2 (en) Modulators of the integrated stress pathway
ES2660831T3 (es) Derivados de imidazol condensados útiles como inhibidores de IDO
JP6231226B2 (ja) ピロリジン−2,5−ジオン誘導体、医薬組成物およびido1阻害剤としての使用のための方法
JP6031122B2 (ja) 抗微生物療法のための三環式ホウ素化合物
AU2018358346A1 (en) Modulators of the integrated stress pathway
JP7595004B2 (ja) 甲状腺ホルモン受容体ベータアゴニスト化合物
RU2717577C2 (ru) Производное имидазоизоиндола, способ его получения и медицинское применение
WO2020223536A1 (en) Substituted cyclolakyls as modulators of the integrated stress pathway
EP3807251B1 (en) Phenyl and pyridinyl substituted imidazoles as modulators of roryt
BR112020008817B1 (pt) Compostos moduladores da via de estresse integrada referência cruzada a pedidos relacionados
RU2013128448A (ru) Производные триазола в качестве ингибиторов сигнального пути wnt
CA2901022A1 (en) Substituted pyridine compounds as inhibitors of histone demethylases
TW202342027A (zh) Prmt5-mta抑制劑
EP3774755B1 (en) Spirocyclic compounds as modulators of indoleamine 2,3-dioxygenase
JP2020516616A5 (cg-RX-API-DMAC7.html)
WO2014059314A1 (en) Treating brain cancer using agelastatin a (aa) and analogues thereof
JP2025118609A (ja) Nurr1受容体調節因子
JP5614858B2 (ja) 新規コルチスタチンa類似体およびその用途
CA3134405A1 (en) Thienoheterocyclic derivative, preparation method therefor and medical use thereof
CN109956927A (zh) 苯并咪唑类衍生物、其制备方法及其在医药学上的应用
WO1997049388A1 (en) Remedies for renal diseases and organ-preserving agents
JP2017137323A (ja) 新規抗がん剤
TWI827576B (zh) 吲哚胺2,3-雙加氧酶抑制劑以及它們在醫學上的應用